Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2018-04-10 | Dr. Thiel brings 25 years of proven global biopharmaceutical industry experience, including rare and orphan diseases. |
Data sourced from SEC filings. Last updated: 2025-07-01